Despite considerable advancements in therapeutic approaches, neuropathic pain remains a globally prevalent and challenging source of chronic suffering, underscoring the urgent demand for innovative treatment strategies. Here, we investigated the role of macrophage migration inhibitory factor (MIF) in neuropathic pain using a rodent model of chronic constriction injury (CCI) to the sciatic nerve, approved by the Ethical Committee of Animal Use and Care. Mechanical thresholds (von Frey hairs) and thermal latencies (hot plate) were measured, alongside spinal MIF expression, pyroptosis markers (e.g., GSDMD-N), and inflammatory cytokines (IL-1β, IL-6, and TNF-α). Our results showed that spinal MIF levels surged post-CCI, peaking on day 14 (p < 0.001), and drove microglial M1 polarization and inflammatory cytokine release (all p < 0.01). Notably, MIF activated the NLRP3 inflammasome, exacerbating neuronal pyroptosis (p < 0.01). These effects were mitigated by MIF inhibitor ISO-1 or NF-κB inhibitor PDTC, which reduced neuroinflammation and pain hypersensitivity. Collectively, this study reveals that MIF promotes NLRP3 inflammasome-mediated neuronal pyroptosis and microglial polarization via the NF-κB pathway, providing novel mechanistic insights into neuropathic pain alleviation through MIF inhibition.
{"title":"MIF-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Spinal Neurons and Microglial Polarization Facilitate Neuropathic Pain Progression.","authors":"Feng Zhou, Yue Tian, Wei Liao, Qingling Ma, Han Bao, Fanqing Meng, Jingjing Jiang","doi":"10.1155/anrp/6624776","DOIUrl":"10.1155/anrp/6624776","url":null,"abstract":"<p><p>Despite considerable advancements in therapeutic approaches, neuropathic pain remains a globally prevalent and challenging source of chronic suffering, underscoring the urgent demand for innovative treatment strategies. Here, we investigated the role of macrophage migration inhibitory factor (MIF) in neuropathic pain using a rodent model of chronic constriction injury (CCI) to the sciatic nerve, approved by the Ethical Committee of Animal Use and Care. Mechanical thresholds (von Frey hairs) and thermal latencies (hot plate) were measured, alongside spinal MIF expression, pyroptosis markers (e.g., GSDMD-N), and inflammatory cytokines (IL-1β, IL-6, and TNF-α). Our results showed that spinal MIF levels surged post-CCI, peaking on day 14 (<i>p</i> < 0.001), and drove microglial M1 polarization and inflammatory cytokine release (all <i>p</i> < 0.01). Notably, MIF activated the NLRP3 inflammasome, exacerbating neuronal pyroptosis (<i>p</i> < 0.01). These effects were mitigated by MIF inhibitor ISO-1 or NF-κB inhibitor PDTC, which reduced neuroinflammation and pain hypersensitivity. Collectively, this study reveals that MIF promotes NLRP3 inflammasome-mediated neuronal pyroptosis and microglial polarization via the NF-κB pathway, providing novel mechanistic insights into neuropathic pain alleviation through MIF inhibition.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"6624776"},"PeriodicalIF":1.3,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Compare the clinical efficacy of CT-guided blunt versus sharp needles for dorsal root ganglion-pulsed radiofrequency (DRG-PRF) in treating zoster-associated pain (ZAP).
Method: This retrospective study analyzed 70 ZAP patients receiving CT-guided DRG-PRF between January 2021 and December 2024. Participants were divided into the blunt needle group (BNG, n = 30) and the sharp needle group (SNG, n = 40). Evaluated endpoints encompassed SF-MPQ scores, postoperative analgesia use, intraprocedural trajectory pain (NRS), operative time, number of CT scan slices, and incidence of complications.
Result: The BN group showed lower puncture NRS scores, shorter operative time, and fewer CT scan layers than the SN group (p < 0.05). SF-MPQ scores (PRI, VAS, and PPI) decreased in both groups postoperatively (p < 0.05), with lower PRI and PPI in the BN group at Day 1, Week 1, and Months 1 and 3 (p < 0.05). Pregabalin use was lower in the BN group at Months 3 and 6, and tramadol use was lower at Week 1 and Month 1 (p < 0.05).
Conclusion: CT-guided DRG-PRF demonstrates good analgesic efficacy in the treatment of ZAP. Compared with sharp needles, blunt needles show superior performance in terms of intraoperative puncture pain, procedure duration, radiation exposure, and postoperative medication use. As an optimized puncture instrument for DRG-PRF, the blunt needle holds promise for broader clinical application and warrants further promotion.
Trial registration: Chinese Clinical Trial Registry: ChiCTR2500102560.
目的:比较ct引导下钝针与尖针背根神经节脉冲射频(DRG-PRF)治疗带状疱疹相关疼痛(ZAP)的临床疗效。方法:本回顾性研究分析了2021年1月至2024年12月期间接受ct引导DRG-PRF治疗的70例ZAP患者。将受试者分为钝针组(BNG, n = 30)和尖针组(SNG, n = 40)。评估终点包括SF-MPQ评分、术后镇痛使用、术中疼痛轨迹(NRS)、手术时间、CT扫描片数和并发症发生率。结果:BN组穿刺NRS评分低于SN组,手术时间短,CT扫描层数少(p < 0.05)。两组术后SF-MPQ评分(PRI、VAS和PPI)均下降(p < 0.05), BN组在第1天、第1周、第1个月和第3个月的PRI和PPI较低(p < 0.05)。BN组第3、6个月普瑞巴林用量较低,第1周、第1个月曲马多用量较低(p < 0.05)。结论:ct引导DRG-PRF治疗ZAP具有良好的镇痛效果。与尖针相比,钝针在术中穿刺疼痛、手术时间、辐射暴露和术后药物使用方面表现出优越的性能。钝针作为DRG-PRF的优化穿刺器,具有更广泛的临床应用前景,值得进一步推广。试验注册:中国临床试验注册中心:ChiCTR2500102560。
{"title":"Advantages of Blunt Radiofrequency Needles in CT-Guided Dorsal Root Ganglion Pulsed Radiofrequency for the Treatment of Zoster-Associated Pain.","authors":"Guanghui Zhang, Jing Yang, Xin Yao, Kai Luo, Zhiji Chen, Shuxiu Feng, Chunfang Wang, Xiaolan Gao, Zelin Weng","doi":"10.1155/anrp/8776779","DOIUrl":"10.1155/anrp/8776779","url":null,"abstract":"<p><strong>Objective: </strong>Compare the clinical efficacy of CT-guided blunt versus sharp needles for dorsal root ganglion-pulsed radiofrequency (DRG-PRF) in treating zoster-associated pain (ZAP).</p><p><strong>Method: </strong>This retrospective study analyzed 70 ZAP patients receiving CT-guided DRG-PRF between January 2021 and December 2024. Participants were divided into the blunt needle group (BNG, <i>n</i> = 30) and the sharp needle group (SNG, <i>n</i> = 40). Evaluated endpoints encompassed SF-MPQ scores, postoperative analgesia use, intraprocedural trajectory pain (NRS), operative time, number of CT scan slices, and incidence of complications.</p><p><strong>Result: </strong>The BN group showed lower puncture NRS scores, shorter operative time, and fewer CT scan layers than the SN group (<i>p</i> < 0.05). SF-MPQ scores (PRI, VAS, and PPI) decreased in both groups postoperatively (<i>p</i> < 0.05), with lower PRI and PPI in the BN group at Day 1, Week 1, and Months 1 and 3 (<i>p</i> < 0.05). Pregabalin use was lower in the BN group at Months 3 and 6, and tramadol use was lower at Week 1 and Month 1 (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>CT-guided DRG-PRF demonstrates good analgesic efficacy in the treatment of ZAP. Compared with sharp needles, blunt needles show superior performance in terms of intraoperative puncture pain, procedure duration, radiation exposure, and postoperative medication use. As an optimized puncture instrument for DRG-PRF, the blunt needle holds promise for broader clinical application and warrants further promotion.</p><p><strong>Trial registration: </strong>Chinese Clinical Trial Registry: ChiCTR2500102560.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"8776779"},"PeriodicalIF":1.3,"publicationDate":"2025-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12597763/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145494285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: This study aimed to compare general anesthesia (GA) and sedoanalgesia (SA) with dexmedetomidine in terms of anesthetic and surgical outcomes in dacryocystorhinostomy (DCR) under bispectral index (BIS) monitoring.
Methods: In this prospective randomized controlled study, 44 adult patients (≥ 18 y) were divided into two groups. Standard GA was induced in the GA group (n = 22), and dexmedetomidine-based SA in the SA group (n = 22). BIS monitoring was performed in all patients. Hemodynamic parameters, amount of intraoperative bleeding, duration of anesthesia and surgery, postoperative pain scores, complications, and patient and surgeon satisfaction were recorded.
Results: The hemodynamic parameters, amount of intraoperative bleeding, duration of anesthesia and surgery, postoperative pain score, complications, and patient and surgeon satisfaction were similar between the two groups. Patient satisfaction was significantly higher in the SA group (p = 0.033).
Conclusions: This study suggests that SA with dexmedetomidine accompanied by BIS monitoring can be an alternative to GA in selected patients undergoing external DCR surgery, because the anesthetic and surgical processes are similar to those of GA, and patient satisfaction is higher than that with GA.
{"title":"Comparison of Anesthetic and Surgical Outcomes Between General Anesthesia and Dexmedetomidine-Based Sedoanalgesia in Dacryocystorhinostomy Surgery With Bispectral Index Monitoring.","authors":"Utku Sağlam, Sertaç Argun Kıvanç, Nermin Kelebek Girgin","doi":"10.1155/anrp/6650312","DOIUrl":"10.1155/anrp/6650312","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to compare general anesthesia (GA) and sedoanalgesia (SA) with dexmedetomidine in terms of anesthetic and surgical outcomes in dacryocystorhinostomy (DCR) under bispectral index (BIS) monitoring.</p><p><strong>Methods: </strong>In this prospective randomized controlled study, 44 adult patients (≥ 18 y) were divided into two groups. Standard GA was induced in the GA group (<i>n</i> = 22), and dexmedetomidine-based SA in the SA group (<i>n</i> = 22). BIS monitoring was performed in all patients. Hemodynamic parameters, amount of intraoperative bleeding, duration of anesthesia and surgery, postoperative pain scores, complications, and patient and surgeon satisfaction were recorded.</p><p><strong>Results: </strong>The hemodynamic parameters, amount of intraoperative bleeding, duration of anesthesia and surgery, postoperative pain score, complications, and patient and surgeon satisfaction were similar between the two groups. Patient satisfaction was significantly higher in the SA group (<i>p</i> = 0.033).</p><p><strong>Conclusions: </strong>This study suggests that SA with dexmedetomidine accompanied by BIS monitoring can be an alternative to GA in selected patients undergoing external DCR surgery, because the anesthetic and surgical processes are similar to those of GA, and patient satisfaction is higher than that with GA.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov identifier: NCT05397301.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"6650312"},"PeriodicalIF":1.3,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12586881/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145457558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-28eCollection Date: 2025-01-01DOI: 10.1155/anrp/2753707
Jun Ni, Huiying Zhang, Chenyang Xu, Xiali Qian, Huiling Yu, Zijun Tian, Mao Mao, Shanwu Feng
<p><strong>Background: </strong>The proportion of advanced maternal age (AMA) parturients in China has gradually increased. AMA is considered a risk factor for adverse maternal and fetal outcomes. Goal-directed fluid therapy (GDFT) was used to guide perioperative volume management in order to reduce spinal anesthesia-induced hypotension and optimize maternal and infant outcomes for AMA parturients undergoing cesarean section. The primary endpoint of this study was the incidence of hypotension induced by spinal anesthesia in AMA parturients undergoing cesarean section. Secondary outcomes included intraoperative infusion volume, time to first postoperative flatus, postoperative blood loss within 24 h, neonatal 1-min and 5-min Apgar scores, umbilical artery blood gas analysis, and NICU transfer rate.</p><p><strong>Methods: </strong>A total of 69 AMA parturients with BMI ≤ 35 kg/m<sup>2</sup> who underwent elective cesarean section with spinal anesthesia were randomly divided into the control group (Group C, <i>n</i> = 35) and the GDFT group (Group G, <i>n</i> = 34). Group C parturients received compound sodium lactate infusion of 20 mL·kg<sup>-1</sup>·h<sup>-1</sup> before delivery, which was reduced to 5 mL·kg<sup>-1</sup>·h<sup>-1</sup> after delivery. Group G parturients were first given compound sodium lactate 3 mL/kg within 3 min after entering the operating room. Thereafter, under the guidance of transthoracic echocardiography (TTE), when the Δ stroke volume (ΔSV) was ≤ 10%, compound sodium lactate was infused at 5 mL·kg<sup>-1</sup>·h<sup>-1</sup>; when the ΔSV was > 10%, the liquid was continued given at 3 mL·kg<sup>-1</sup>·3 min<sup>-1</sup> until ΔSV ≤ 10%, followed by infusion rate of 5 mL·kg<sup>-1</sup>·h<sup>-1</sup>. The primary endpoint was defined as the incidence of hypotension induced by spinal anesthesia in AMA parturients undergoing cesarean section before anesthesia (T0), after completion of subarachnoid block (T1), at fetal delivery (T2), and at the end of surgery (T3), with hypotension defined as systolic blood pressure (SBP) ≤ 80% of baseline value or mean arterial pressure (MAP) ≤ 65 mmHg. Secondary endpoints included intraoperative infusion volume, time to first postoperative flatus, postoperative blood loss within 24 h, neonatal 1-min and 5-min Apgar scores, umbilical artery blood gas analysis, and NICU transfer rate.</p><p><strong>Result: </strong>Compared with Group C, the amount of predelivery fluid and intraoperative infusion in Group G was significantly reduced (<i>p</i> < 0.001), and the incidence of intraoperative hypotension in Group G was significantly decreased (<i>p</i> < 0.05). Compared with T0, SBP was significantly decreased at T1-T3 in both groups (<i>p</i> < 0.05), SV was significantly decreased at T1 in both groups. Compared with Group C, CO was significantly decreased at T1 in Group G (<i>p</i> < 0.05). The first postoperative flatus time was 36.71 ± 10.65 h vs. 31.62 ± 9.19 h, the first ambulation time
{"title":"Effect of Goal-Directed Fluid Therapy on Hypotension From Spinal Anesthesia in Older Parturients Having Cesarean Section: A Randomized Controlled Trial.","authors":"Jun Ni, Huiying Zhang, Chenyang Xu, Xiali Qian, Huiling Yu, Zijun Tian, Mao Mao, Shanwu Feng","doi":"10.1155/anrp/2753707","DOIUrl":"10.1155/anrp/2753707","url":null,"abstract":"<p><strong>Background: </strong>The proportion of advanced maternal age (AMA) parturients in China has gradually increased. AMA is considered a risk factor for adverse maternal and fetal outcomes. Goal-directed fluid therapy (GDFT) was used to guide perioperative volume management in order to reduce spinal anesthesia-induced hypotension and optimize maternal and infant outcomes for AMA parturients undergoing cesarean section. The primary endpoint of this study was the incidence of hypotension induced by spinal anesthesia in AMA parturients undergoing cesarean section. Secondary outcomes included intraoperative infusion volume, time to first postoperative flatus, postoperative blood loss within 24 h, neonatal 1-min and 5-min Apgar scores, umbilical artery blood gas analysis, and NICU transfer rate.</p><p><strong>Methods: </strong>A total of 69 AMA parturients with BMI ≤ 35 kg/m<sup>2</sup> who underwent elective cesarean section with spinal anesthesia were randomly divided into the control group (Group C, <i>n</i> = 35) and the GDFT group (Group G, <i>n</i> = 34). Group C parturients received compound sodium lactate infusion of 20 mL·kg<sup>-1</sup>·h<sup>-1</sup> before delivery, which was reduced to 5 mL·kg<sup>-1</sup>·h<sup>-1</sup> after delivery. Group G parturients were first given compound sodium lactate 3 mL/kg within 3 min after entering the operating room. Thereafter, under the guidance of transthoracic echocardiography (TTE), when the Δ stroke volume (ΔSV) was ≤ 10%, compound sodium lactate was infused at 5 mL·kg<sup>-1</sup>·h<sup>-1</sup>; when the ΔSV was > 10%, the liquid was continued given at 3 mL·kg<sup>-1</sup>·3 min<sup>-1</sup> until ΔSV ≤ 10%, followed by infusion rate of 5 mL·kg<sup>-1</sup>·h<sup>-1</sup>. The primary endpoint was defined as the incidence of hypotension induced by spinal anesthesia in AMA parturients undergoing cesarean section before anesthesia (T0), after completion of subarachnoid block (T1), at fetal delivery (T2), and at the end of surgery (T3), with hypotension defined as systolic blood pressure (SBP) ≤ 80% of baseline value or mean arterial pressure (MAP) ≤ 65 mmHg. Secondary endpoints included intraoperative infusion volume, time to first postoperative flatus, postoperative blood loss within 24 h, neonatal 1-min and 5-min Apgar scores, umbilical artery blood gas analysis, and NICU transfer rate.</p><p><strong>Result: </strong>Compared with Group C, the amount of predelivery fluid and intraoperative infusion in Group G was significantly reduced (<i>p</i> < 0.001), and the incidence of intraoperative hypotension in Group G was significantly decreased (<i>p</i> < 0.05). Compared with T0, SBP was significantly decreased at T1-T3 in both groups (<i>p</i> < 0.05), SV was significantly decreased at T1 in both groups. Compared with Group C, CO was significantly decreased at T1 in Group G (<i>p</i> < 0.05). The first postoperative flatus time was 36.71 ± 10.65 h vs. 31.62 ± 9.19 h, the first ambulation time","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"2753707"},"PeriodicalIF":1.3,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12568773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145407829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-26eCollection Date: 2025-01-01DOI: 10.1155/anrp/5927191
Sunil Bhatta, Subrata Podder, Shyam Charan Meena
Context: Cause of "emergence delirium" (ED) after general anesthesia with volatile anesthetics in adults remains unclear. While low "fresh gas flow" (FGF) is integral to current anesthesia practice, there is limited literature about FGF's role in ED.
Aims: To compare ED in patients receiving high or low FGF during anesthesia with sevoflurane while undergoing laparoscopic cholecystectomy for gallstone disease.
Settings and design: Prospective randomized double-blind study.
Methods and materials: One hundred American Society of Anesthesiologists (ASA) I and II patients, aged 18-50 years, were randomized to a low FGF or high FGF group of 50 patients each. After preoxygenation with 100% oxygen for 3 min, patients were induced. The low FGF group received 4 L for 5 min, followed by 1 L till the end, while the high FGF group received 4 L throughout. Sevoflurane, nitrous oxide, and oxygen (N2O : O2 = 1 : 1) were used to maintain minimum alveolar concentration (MAC) value of ≥ 1.2. A blind independent observer assessed ED by Richmond agitation-sedation scale (RASS).
Statistical analysis used: Student's T-test, chi-square test, and Mann-Whitney U test.
Results: Postoperative lactate was significantly higher in the low FGF group compared with the high FGF group (1.49 ± 0.69 vs. 1.05 ± 0.54 mmol/L, p ≤ 0.001). RASS scores were also higher with low FGF both immediately after PACU admission (median 1 [IQR 1-1] vs. -1 [IQR -2-0], p < 0.001) and at 10 min (median 0 [IQR 0-1] vs. 0 [IQR -1-0], p < 0.001), while scores at 20 and 30 min were comparable.
Conclusions: ED and lactate levels were significantly higher in patients receiving low FGF compared to high FGF during anesthesia.
背景:成人使用挥发性麻醉药全麻后出现“突发性谵妄”(ED)的原因尚不清楚。虽然低“新鲜气体流量”(FGF)是当前麻醉实践中不可或缺的一部分,但关于FGF在ED中的作用的文献有限。目的:比较七氟醚麻醉下高或低FGF的患者在腹腔镜胆囊切除术治疗胆结石疾病时的ED。设置和设计:前瞻性随机双盲研究。方法和材料:100例年龄18-50岁的美国麻醉学会(ASA) I和II级患者随机分为低FGF组和高FGF组各50例。100%氧预充氧3min后诱导。低FGF组给予4l,持续5min,随后再给予1l,直至结束;高FGF组全程给予4l。七氟烷、氧化亚氮和氧气(N2O: O2 = 1:1)维持最低肺泡浓度(MAC)≥1.2。采用Richmond激动-镇静量表(RASS)对ED进行独立盲观察。采用的统计分析:学生t检验、卡方检验和Mann-Whitney U检验。结果:低FGF组术后乳酸水平明显高于高FGF组(1.49±0.69 vs 1.05±0.54 mmol/L, p≤0.001)。低FGF患者在PACU入院后立即(中位数1 [IQR 1-1] vs. -1 [IQR -2-0], p < 0.001)和10分钟(中位数0 [IQR 0-1] vs. 0 [IQR -1-0], p < 0.001)的RASS评分也较高,而20和30分钟的评分具有可比性。结论:麻醉期间接受低FGF的患者ED和乳酸水平明显高于接受高FGF的患者。
{"title":"Comparison of Emergence Delirium in Patients Undergoing Laparoscopic Cholecystectomy With High or Low Fresh Gas Flow During Anesthesia: A Prospective Randomized Double-Blind Study.","authors":"Sunil Bhatta, Subrata Podder, Shyam Charan Meena","doi":"10.1155/anrp/5927191","DOIUrl":"10.1155/anrp/5927191","url":null,"abstract":"<p><strong>Context: </strong>Cause of \"emergence delirium\" (ED) after general anesthesia with volatile anesthetics in adults remains unclear. While low \"fresh gas flow\" (FGF) is integral to current anesthesia practice, there is limited literature about FGF's role in ED.</p><p><strong>Aims: </strong>To compare ED in patients receiving high or low FGF during anesthesia with sevoflurane while undergoing laparoscopic cholecystectomy for gallstone disease.</p><p><strong>Settings and design: </strong>Prospective randomized double-blind study.</p><p><strong>Methods and materials: </strong>One hundred American Society of Anesthesiologists (ASA) I and II patients, aged 18-50 years, were randomized to a low FGF or high FGF group of 50 patients each. After preoxygenation with 100% oxygen for 3 min, patients were induced. The low FGF group received 4 L for 5 min, followed by 1 L till the end, while the high FGF group received 4 L throughout. Sevoflurane, nitrous oxide, and oxygen (N<sub>2</sub>O : O<sub>2</sub> = 1 : 1) were used to maintain minimum alveolar concentration (MAC) value of ≥ 1.2. A blind independent observer assessed ED by Richmond agitation-sedation scale (RASS).</p><p><strong>Statistical analysis used: </strong>Student's <i>T</i>-test, chi-square test, and Mann-Whitney <i>U</i> test.</p><p><strong>Results: </strong>Postoperative lactate was significantly higher in the low FGF group compared with the high FGF group (1.49 ± 0.69 vs. 1.05 ± 0.54 mmol/L, <i>p</i> ≤ 0.001). RASS scores were also higher with low FGF both immediately after PACU admission (median 1 [IQR 1-1] vs. -1 [IQR -2-0], <i>p</i> < 0.001) and at 10 min (median 0 [IQR 0-1] vs. 0 [IQR -1-0], <i>p</i> < 0.001), while scores at 20 and 30 min were comparable.</p><p><strong>Conclusions: </strong>ED and lactate levels were significantly higher in patients receiving low FGF compared to high FGF during anesthesia.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"5927191"},"PeriodicalIF":1.3,"publicationDate":"2025-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145385955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-06eCollection Date: 2025-01-01DOI: 10.1155/anrp/5336172
Xuelong Zhou, Jia Liu, Jingming Zhu, Xiuhong Jiang, Qi Zou
Background: Obese patients undergoing general anesthesia are at heightened risk for postoperative pulmonary complications (PPCs) due to impaired respiratory mechanics. While lung-protective ventilation strategies are widely adopted, the role of intraoperative inspiratory oxygen fraction (FiO2) in this population remains controversial.
Methods: We conducted a prospective, randomized controlled trial comparing low (FiO2 40%) versus high (FiO2 80%) intraoperative oxygen concentration in 113 obese patients undergoing elective laparoscopic bariatric surgery. All patients received standardized lung-protective ventilation. The primary outcome was the incidence and severity of PPCs within 5 postoperative days. Secondary outcomes included hospital length of stay, mortality, postoperative nausea and vomiting (PONV), and surgical site infection (SSI).
Results: The incidence of PPCs was 70.7% in the high FiO2 group and 55.5% in the low FiO2 group (p=0.08). Grade ≥ 3 PPCs occurred only in the high FiO2 group (3.4%). The average PPC severity score was lower in the low FiO2 group (0.9 ± 0.9 vs. 1.2 ± 0.9, p=0.08). No differences were observed in hospital stay, mortality, or SSI. PONV was more frequent in the low FiO2 group (43.6% vs. 27.6%, p=0.08).
Conclusion: Although the difference was not statistically significant, the observed lower incidence of PPCs in the low FiO2 group may indicate a potential clinical effect. Larger, multicenter trials are warranted to confirm these results and optimize oxygen management in obese surgical patients. Trial Registration: Chinese Clinical Trial Registry: ChiCTR2300076656.
{"title":"Low vs. High Inspiratory Oxygen Fraction During Mechanical Ventilation in Obese Patients: Impact on Postoperative Pulmonary Outcomes.","authors":"Xuelong Zhou, Jia Liu, Jingming Zhu, Xiuhong Jiang, Qi Zou","doi":"10.1155/anrp/5336172","DOIUrl":"10.1155/anrp/5336172","url":null,"abstract":"<p><strong>Background: </strong>Obese patients undergoing general anesthesia are at heightened risk for postoperative pulmonary complications (PPCs) due to impaired respiratory mechanics. While lung-protective ventilation strategies are widely adopted, the role of intraoperative inspiratory oxygen fraction (FiO<sub>2</sub>) in this population remains controversial.</p><p><strong>Methods: </strong>We conducted a prospective, randomized controlled trial comparing low (FiO<sub>2</sub> 40%) versus high (FiO<sub>2</sub> 80%) intraoperative oxygen concentration in 113 obese patients undergoing elective laparoscopic bariatric surgery. All patients received standardized lung-protective ventilation. The primary outcome was the incidence and severity of PPCs within 5 postoperative days. Secondary outcomes included hospital length of stay, mortality, postoperative nausea and vomiting (PONV), and surgical site infection (SSI).</p><p><strong>Results: </strong>The incidence of PPCs was 70.7% in the high FiO<sub>2</sub> group and 55.5% in the low FiO<sub>2</sub> group (<i>p</i>=0.08). Grade ≥ 3 PPCs occurred only in the high FiO<sub>2</sub> group (3.4%). The average PPC severity score was lower in the low FiO<sub>2</sub> group (0.9 ± 0.9 vs. 1.2 ± 0.9, <i>p</i>=0.08). No differences were observed in hospital stay, mortality, or SSI. PONV was more frequent in the low FiO<sub>2</sub> group (43.6% vs. 27.6%, <i>p</i>=0.08).</p><p><strong>Conclusion: </strong>Although the difference was not statistically significant, the observed lower incidence of PPCs in the low FiO<sub>2</sub> group may indicate a potential clinical effect. Larger, multicenter trials are warranted to confirm these results and optimize oxygen management in obese surgical patients. <b>Trial Registration:</b> Chinese Clinical Trial Registry: ChiCTR2300076656.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"5336172"},"PeriodicalIF":1.3,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12517982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145290669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-01-01DOI: 10.1155/anrp/3267589
Zhen Wan, Haiming Liao, Jinhuo Qin, Simin Tang, Jingjing Su, Jun Zhou
Background: Continuous adductor canal block (CACB) is a highly effective analgesic technique in total knee arthroplasty. The brachy axis approach (BA) is currently the common method used for CACB. Although CACB for BA offers advantages such as easy localization and operation due to clear anatomy, it has limitations such as short catheter placement and a high dislocation rate. These limitations can result in insufficient postoperative analgesia and impact patient rehabilitation. The perineural catheters placed parallel for CACB increases the difficulty of operation and the risk of puncture injury. In this study, the authors first applied the oblique approach (OA) to CACB and systematically compared the postoperative analgesic effects and adverse reactions of these two CACB methods with different puncture angles.
Methods: Ninety subjects who underwent TKA were randomly assigned to receive ultrasound-guided CACB using either the OA or BA. The main outcome measured was the exercise maximum visual analog scale (VAS) score at 72 h after surgery. The main safety indicator was the rate of catheter dislocation. The data were recorded and analyzed using analysis of variance, with adjustments made for baseline characteristics.
Results: There was no statistical difference in catheter placement time or postoperative resting VAS between the two groups. However, the postoperative exercise VAS and the incidence of postoperative adverse effects were lower in the OA group compared to the BA group.
Conclusions: The OA of CACB applied after TKA improved the analgesic effect during the postoperative motor state compared to the BA and reduced the incidence of adverse reactions, without increasing the catheterization procedure time.
Trial registration: Chinese Clinical Trial Registry: ChiCTR2200059889.
{"title":"The Efficacy of Continuous Adductor Canal Block Oblique Approach to Postoperative Analgesia After Total Knee Arthroplasty: A Randomized, Double-Blinded, Controlled Clinical Trial.","authors":"Zhen Wan, Haiming Liao, Jinhuo Qin, Simin Tang, Jingjing Su, Jun Zhou","doi":"10.1155/anrp/3267589","DOIUrl":"10.1155/anrp/3267589","url":null,"abstract":"<p><strong>Background: </strong>Continuous adductor canal block (CACB) is a highly effective analgesic technique in total knee arthroplasty. The brachy axis approach (BA) is currently the common method used for CACB. Although CACB for BA offers advantages such as easy localization and operation due to clear anatomy, it has limitations such as short catheter placement and a high dislocation rate. These limitations can result in insufficient postoperative analgesia and impact patient rehabilitation. The perineural catheters placed parallel for CACB increases the difficulty of operation and the risk of puncture injury. In this study, the authors first applied the oblique approach (OA) to CACB and systematically compared the postoperative analgesic effects and adverse reactions of these two CACB methods with different puncture angles.</p><p><strong>Methods: </strong>Ninety subjects who underwent TKA were randomly assigned to receive ultrasound-guided CACB using either the OA or BA. The main outcome measured was the exercise maximum visual analog scale (VAS) score at 72 h after surgery. The main safety indicator was the rate of catheter dislocation. The data were recorded and analyzed using analysis of variance, with adjustments made for baseline characteristics.</p><p><strong>Results: </strong>There was no statistical difference in catheter placement time or postoperative resting VAS between the two groups. However, the postoperative exercise VAS and the incidence of postoperative adverse effects were lower in the OA group compared to the BA group.</p><p><strong>Conclusions: </strong>The OA of CACB applied after TKA improved the analgesic effect during the postoperative motor state compared to the BA and reduced the incidence of adverse reactions, without increasing the catheterization procedure time.</p><p><strong>Trial registration: </strong>Chinese Clinical Trial Registry: ChiCTR2200059889.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"3267589"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503995/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Considering the importance of hemodynamic stability during tracheal tube removal in patients undergoing surgery with general anesthesia. This study was designed to evaluate and compare the impacts of intravenous dexmedetomidine and remifentanil on mitigating the cardiovascular responses associated with extubation in individuals receiving general anesthesia. Methods: In this clinical study, a cohort of 90 patients scheduled for surgical procedures under general anesthesia was evenly divided into three groups of 30, receiving dexmedetomidine (0.7 μg/kg), remifentanil (0.3 μg/kg), or a placebo of normal saline. Hemodynamic metrics, such as heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP), were assessed at baseline, prior to extubation, and at intervals of 1, 3, 5, and 10 min following extubation. Results: At 1-10 min postextubation, the control group (C) had a higher HR than the dexmedetomidine (D) and remifentanil (R) groups (p < 0.001), there was no difference in HR between the D and R groups (p=0.57). There was a significant difference in SBP between D and C groups (p=0.09) and between D and C groups (p=0.047). No significant differences in DBP were found among the groups (p > 0.0.5). There was a notable difference in MAP changes between Groups D and C (p=0.010), but there were no differences between Groups D and R (p=0.14) and R and C (p=0.84). In addition, the incidence of tachycardia in Group C was significantly higher than that in other groups (p < 0.001). In addition, the incidence of tachycardia in Group C was significantly higher than that in other groups (p < 0.001). Conclusion: Administering dexmedetomidine at a dosage of 0.7 μg/kg enhances hemodynamic stability during extubation and decreases the occurrence of hemodynamic disturbances and coughing when compared to remifentanil at 0.3 μg/kg and the control group. Therefore, it is regarded as the optimal option for alleviating cardiovascular responses during extubation. Trial Registration: Iranian Clinical Trials Registry: IRCT20200825048515N74.
{"title":"Comparison of the Effects of Intravenous Dexmedetomidine and Remifentanil in Attenuating the Cardiovascular Response to Extubation in Patients Under General Anesthesia: A Randomized Clinical Trial.","authors":"Hamidreza Shetabi, Mehrdad Masoudifar, Hossein Mahjobipoor, Faezeh Poorsajad","doi":"10.1155/anrp/9949776","DOIUrl":"10.1155/anrp/9949776","url":null,"abstract":"<p><p><b>Background:</b> Considering the importance of hemodynamic stability during tracheal tube removal in patients undergoing surgery with general anesthesia. This study was designed to evaluate and compare the impacts of intravenous dexmedetomidine and remifentanil on mitigating the cardiovascular responses associated with extubation in individuals receiving general anesthesia. <b>Methods:</b> In this clinical study, a cohort of 90 patients scheduled for surgical procedures under general anesthesia was evenly divided into three groups of 30, receiving dexmedetomidine (0.7 μg/kg), remifentanil (0.3 μg/kg), or a placebo of normal saline. Hemodynamic metrics, such as heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP), were assessed at baseline, prior to extubation, and at intervals of 1, 3, 5, and 10 min following extubation. <b>Results:</b> At 1-10 min postextubation, the control group (C) had a higher HR than the dexmedetomidine (D) and remifentanil (R) groups (<i>p</i> < 0.001), there was no difference in HR between the D and R groups (<i>p</i>=0.57). There was a significant difference in SBP between D and C groups (<i>p</i>=0.09) and between D and C groups (<i>p</i>=0.047). No significant differences in DBP were found among the groups (<i>p</i> > 0.0.5). There was a notable difference in MAP changes between Groups D and C (<i>p</i>=0.010), but there were no differences between Groups D and R (<i>p</i>=0.14) and R and C (<i>p</i>=0.84). In addition, the incidence of tachycardia in Group C was significantly higher than that in other groups (<i>p</i> < 0.001). In addition, the incidence of tachycardia in Group C was significantly higher than that in other groups (<i>p</i> < 0.001). <b>Conclusion:</b> Administering dexmedetomidine at a dosage of 0.7 μg/kg enhances hemodynamic stability during extubation and decreases the occurrence of hemodynamic disturbances and coughing when compared to remifentanil at 0.3 μg/kg and the control group. Therefore, it is regarded as the optimal option for alleviating cardiovascular responses during extubation. <b>Trial Registration:</b> Iranian Clinical Trials Registry: IRCT20200825048515N74.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"9949776"},"PeriodicalIF":1.3,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145231361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Emergence delirium, characterized by early postoperative behavioral changes in pediatric patients, poses potential risks to patient safety, resulting in extended hospital stays and increased medical costs. Remimazolam has a rapid onset, moderate half-life, and lower compression on respiratory and circulatory function. This double-blind randomized study aims to compare the incidence of emergence delirium in pediatric patients who received a single dose of remimazolam or dexmedetomidine before the end of sevoflurane anesthesia. Methods: A total of 110 pediatric patients aged 2-12 years, American Society of Anesthesiologists (ASA) Class I or II, undergoing elective tonsillectomy and adenoidectomy were included in this study and randomized into the dexmedetomidine group and remimazolam group (R group) (n = 55). Inhalation of sevoflurane was stopped 15 min before surgery after asking the surgeon's opinion, and either 0.2 mg/kg of remimazolam or 0.2 μg/kg of dexmedetomidine was administered. The main and secondary results of the research were both analyzed with the intention-to-treat analysis. The main outcome observed in this study was the incidence of emergence delirium in both groups. Secondary outcomes were vital signs at various time points after administration, Pediatric Anesthesia Emergence Delirium (PAED) scale score for delirium, extubation time, the length of time in the postanesthesia care unit (PACU), postoperative adverse events, and parental satisfaction. Results: The intention-to-treat analysis indicated that the mean age of patients was 5.7 ± 0.4 years, with 62 (56.4%) of them being male. The incidence of emergence delirium was 25.5% overall, with no significant difference seen between the two groups. Compared to the R group, dexmedetomidine decreased the heart rate significantly (p < 0.001). There were no differences in extubation time, PACU stay, postoperative adverse events, and parental satisfaction between the two groups. In addition, age is an independent risk factor contributing to the emergence delirium. Conclusions: Discontinuing the inhalation of sevoflurane 15 min before the end of the procedure and administering 0.2 mg/kg of remimazolam intravenously did not show superiority over 0.2 μg/kg of dexmedetomidine in preventing emergence delirium. Trial Registration: Chinese Registry of Clinical Trials: ChiCTR2300072526.
{"title":"A Comparison of Single Dose Remimazolam With Dexmedetomidine for the Prevention of Emergence Delirium in Children Undergoing Tonsillectomy and Adenoidectomy Surgery Under Sevoflurane Anesthesia: A Randomized Clinical Trial.","authors":"Ting Liu, Jing Zhou, Xi-Xi Wang, Si-Fei Gan, Jie-Qiong Liu, Peng-Fei Zhu, Mei-Hong Li, Fang Luo","doi":"10.1155/anrp/7780635","DOIUrl":"10.1155/anrp/7780635","url":null,"abstract":"<p><p><b>Introduction:</b> Emergence delirium, characterized by early postoperative behavioral changes in pediatric patients, poses potential risks to patient safety, resulting in extended hospital stays and increased medical costs. Remimazolam has a rapid onset, moderate half-life, and lower compression on respiratory and circulatory function. This double-blind randomized study aims to compare the incidence of emergence delirium in pediatric patients who received a single dose of remimazolam or dexmedetomidine before the end of sevoflurane anesthesia. <b>Methods:</b> A total of 110 pediatric patients aged 2-12 years, American Society of Anesthesiologists (ASA) Class I or II, undergoing elective tonsillectomy and adenoidectomy were included in this study and randomized into the dexmedetomidine group and remimazolam group (R group) (<i>n</i> = 55). Inhalation of sevoflurane was stopped 15 min before surgery after asking the surgeon's opinion, and either 0.2 mg/kg of remimazolam or 0.2 μg/kg of dexmedetomidine was administered. The main and secondary results of the research were both analyzed with the intention-to-treat analysis. The main outcome observed in this study was the incidence of emergence delirium in both groups. Secondary outcomes were vital signs at various time points after administration, Pediatric Anesthesia Emergence Delirium (PAED) scale score for delirium, extubation time, the length of time in the postanesthesia care unit (PACU), postoperative adverse events, and parental satisfaction. <b>Results:</b> The intention-to-treat analysis indicated that the mean age of patients was 5.7 ± 0.4 years, with 62 (56.4%) of them being male. The incidence of emergence delirium was 25.5% overall, with no significant difference seen between the two groups. Compared to the R group, dexmedetomidine decreased the heart rate significantly (<i>p</i> < 0.001). There were no differences in extubation time, PACU stay, postoperative adverse events, and parental satisfaction between the two groups. In addition, age is an independent risk factor contributing to the emergence delirium. <b>Conclusions:</b> Discontinuing the inhalation of sevoflurane 15 min before the end of the procedure and administering 0.2 mg/kg of remimazolam intravenously did not show superiority over 0.2 μg/kg of dexmedetomidine in preventing emergence delirium. <b>Trial Registration:</b> Chinese Registry of Clinical Trials: ChiCTR2300072526.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"7780635"},"PeriodicalIF":1.3,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12450552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-28eCollection Date: 2025-01-01DOI: 10.1155/anrp/6832202
Rafail Ioannidis, Despoina Sarridou, Christina Tsigalou, Adamantios Bampoulas, Pelagia Chloropoulou
Nutritional screening is gaining recognition in perioperative medicine, as anesthesiologists need to assess patients' nutritional status to identify malnutrition risks. Poor nutritional status is associated with increased perioperative complications, including postoperative pain. Effective pain management is crucial to prevent acute pain from developing into chronic pain. However, the link between malnutrition and pain is not well established, prompting interest in whether nutritional assessment tools correlate with pain severity. The Mini Nutritional Assessment Short-Form (MNA-SF) is a validated screening tool for geriatric patients, recommended by European Society for Clinical Nutrition and Metabolism (ESPEN) for routine use. The modified Nutrition Risk in Critically Ill (mNUTRIC) score evaluates critically ill patients' nutritional risk, guiding interventions to improve outcomes. This study aimed to explore the relationship between nutritional status, inflammatory markers, and postoperative pain in elderly surgical patients to optimize care. A prospective study involving 108 elderly patients (≥ 70 years) assessed the preoperative nutritional status using MNA-SF, mNUTRIC, Acute Physiology and Chronic Health Evaluation (APACHE), Sequential Organ Failure Assessment (SOFA), and inflammatory biomarkers (C-reactive protein (CRP) and albumin (Alb)). Postoperative pain was measured at surgery, 30 days, and 6 months. Statistical analysis found significant links between the nutritional status and pain outcomes. Higher mNUTRIC and APACHE scores correlated with increased pain, while higher Alb and MNA-SF scores were associated with lower pain levels. Chronic pain at 6 months was strongly linked to poor preoperative nutritional and inflammatory status. Findings suggest that nutritional deficiencies and inflammation are associated with postoperative pain and recovery. Integrating nutritional screening into preoperative assessments could improve outcomes by guiding interventions. Future research should refine predictive models to better understand the complex interplay between nutrition, inflammation, and pain in perioperative care. Trial Registration: ClinicalTrials.gov identifier: NCT06802575.
{"title":"Bridging the Gap: The Impact of Preoperative Nutritional Status and Inflammation in Postoperative Pain in Elderly Patients.","authors":"Rafail Ioannidis, Despoina Sarridou, Christina Tsigalou, Adamantios Bampoulas, Pelagia Chloropoulou","doi":"10.1155/anrp/6832202","DOIUrl":"10.1155/anrp/6832202","url":null,"abstract":"<p><p>Nutritional screening is gaining recognition in perioperative medicine, as anesthesiologists need to assess patients' nutritional status to identify malnutrition risks. Poor nutritional status is associated with increased perioperative complications, including postoperative pain. Effective pain management is crucial to prevent acute pain from developing into chronic pain. However, the link between malnutrition and pain is not well established, prompting interest in whether nutritional assessment tools correlate with pain severity. The Mini Nutritional Assessment Short-Form (MNA-SF) is a validated screening tool for geriatric patients, recommended by European Society for Clinical Nutrition and Metabolism (ESPEN) for routine use. The modified Nutrition Risk in Critically Ill (mNUTRIC) score evaluates critically ill patients' nutritional risk, guiding interventions to improve outcomes. This study aimed to explore the relationship between nutritional status, inflammatory markers, and postoperative pain in elderly surgical patients to optimize care. A prospective study involving 108 elderly patients (≥ 70 years) assessed the preoperative nutritional status using MNA-SF, mNUTRIC, Acute Physiology and Chronic Health Evaluation (APACHE), Sequential Organ Failure Assessment (SOFA), and inflammatory biomarkers (C-reactive protein (CRP) and albumin (Alb)). Postoperative pain was measured at surgery, 30 days, and 6 months. Statistical analysis found significant links between the nutritional status and pain outcomes. Higher mNUTRIC and APACHE scores correlated with increased pain, while higher Alb and MNA-SF scores were associated with lower pain levels. Chronic pain at 6 months was strongly linked to poor preoperative nutritional and inflammatory status. Findings suggest that nutritional deficiencies and inflammation are associated with postoperative pain and recovery. Integrating nutritional screening into preoperative assessments could improve outcomes by guiding interventions. Future research should refine predictive models to better understand the complex interplay between nutrition, inflammation, and pain in perioperative care. <b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT06802575.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2025 ","pages":"6832202"},"PeriodicalIF":1.3,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}